CSWYY (China Shineway Pharmaceutical Group) Interest Expense: $-0.8 Mil (TTM As of Dec. 2025)


CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
92 GF Score
Price $19.25
GF Value $16.85
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Interest Expense?

China Shineway Pharmaceutical Group CSWYY 92 Interest Expense is $-0.8 Mil as of Dec. 2025. GuruFocus rates CSWYY with a GF Score™ of 92/100 and a GF Value™ of $16.85. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China Shineway Pharmaceutical Group's interest expense for the six months ended in Dec. 2025 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China Shineway Pharmaceutical Group's Operating Income for the six months ended in Dec. 2025 was $ 49.5 Mil. China Shineway Pharmaceutical Group's Interest Expense for the six months ended in Dec. 2025 was $ 0.0 Mil. China Shineway Pharmaceutical Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Shineway Pharmaceutical Group  (OTCPK:CSWYY) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Shineway Pharmaceutical Group's Interest Expense for the six months ended in Dec. 2025 was $0.0 Mil. Its Operating Income for the six months ended in Dec. 2025 was $49.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $0.1 Mil.

China Shineway Pharmaceutical Group's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. China Shineway Pharmaceutical Group Ltd has enough cash to cover all of its debt. Its financial situation is stable.

China Shineway Pharmaceutical Group Interest Expense Historical Data

* Premium members only.

The historical data trend for China Shineway Pharmaceutical Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group Interest Expense Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.20 -0.09 -0.38 -0.84 -0.81

China Shineway Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.39 -0.45 -0.82 0.03
CSWYY
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Shineway Pharmaceutical Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.8 Mil mean?
China Shineway Pharmaceutical Group (CSWYY) has a Interest Expense of $-0.8 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on China Shineway Pharmaceutical Group and its competitors.
Is China Shineway Pharmaceutical Group's Interest Expense too high?
China Shineway Pharmaceutical Group's current Interest Expense is $-0.8 Mil. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Interest Expense compare to ZTS?
China Shineway Pharmaceutical Group's Interest Expense of $-0.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current Interest Expense is $-0.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Interest Expense of $-0.8 Mil. The stock's GF Value™ is $16.85, compared to a current price of $19.25 — trading 14.2% above its estimated fair value. The current Interest Expense is $-0.8 Mil. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Interest Expense is $-0.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 14.2% above its estimated GF Value™ of $16.85.

Key valuation signals for CSWYY:

  • Interest Expense: $-0.8 Mil
  • GF Value™: $16.85 vs. price of $19.25 (14.2% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYY

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$16.85
GF Value